Back to search
FDAFDA · Food and drugs·Recall number D-1019-2013

Glutathione 100 mg/mL Injectable, 100mL Vial, Use as Directed, RX, Creative Compounds, Wilsonville, OR 97070.

Published September 18, 2013 · Recall initiated: August 23, 2013

Summary

FDA records drug Class II recall D-1019-2013, published September 18, 2013 and initiated August 23, 2013. Recalling firm: Creative Compounds; Status: Terminated; Reported quantity: 16 vials; Lot: Lot #: 20130715@12, Exp10/13/2013. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Glutathione 100 mg/mL injectable human drug is recalled due to Out Of Specification results or potential bacterial contamination and it was reported as passing by a contract laboratory.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Creative Compounds
Distributor
Oregon and Washington
Lot
Lot #: 20130715@12, Exp10/13/2013
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Glutathione 100 mg/mL Injectable, 100mL Vial, Use as Directed, RX, Creative Compounds, Wilsonville, OR 97070. recalled?

Yes. FDA published recall D-1019-2013 on September 18, 2013. Reported hazard: Glutathione 100 mg/mL injectable human drug is recalled due to Out Of Specification results or potential bacterial contamination and it was reported as passing by a contract laboratory.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit